Login

Mr Karolis Rosickas, CEO, Regeneus Ltd 00:00:00

Share On Facebook Share On Twitter

Karolis was appointed CEO of Regeneus on 2 November 2020.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Transformative consumer brands and the technologies that power them|Amanda Schutzbank,Co-Founder & General Partner,Willow Growth Partners
00:00:00
Lauren Orefice, PhD Assistant Professor in Genetics, Harvard Medical School
00:10:00
State Bank of India's Financial Performance and Economic Insights | Dinesh Khara, Chairman , State Bank of India.
00:10:00
Transitioning Investment Banking Strategies: Embracing Advisory Services and Diversification | C.S. Venkatakrishnan , CEO , Barclays.
00:10:00
Fostering Industry-Union Collaboration for a Net-Zero Skills Agenda | Chris O'Shea, CEO,Centrica PLC.
00:10:00
The secret to gaining muscle after 40|Dr. Tracy Gapin,Urologist & Men’s Health Expert
00:10:00
James Buckley on the Enduring Relevance of 18th Century Values|James Buckley
00:10:00
Embracing Retirement: Leveraging Skills and Flexibility in the Gig Economy
00:00:00
Incidence and Prevalence of Clinical Hypertrophic Cardiomyopathy - Dr. Shahid Karim, a Cardiologist at Mayo Clinic
00:10:00
Stephen Streater: CEO of Forbidden Technologies | Stephen Streater , CEO at Forbidden Technologies plc
00:10:00
Gain informative perspectives on estate planning from Dina Megretskaia of Modera Wealth Management, LLC.
00:00:00
Tomas J. Svoboda, CEO, Elanix Biotechnologies

© 2017 - Neuhu+